Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Vasundhara Rasayans Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹176.90 |
|---|---|
| Day's Range | ₹172.00 - ₹178.00 |
| Open | ₹178.00 |
| 52 Week Range | ₹100.10 - ₹220.00 |
| Volume | 391 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.69 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 9.71 |
| TTM EPS (₹) | 18.22 |
| P/E Ratio | 17.28 |
| Book Value(₹) | 1.38 |
| PAT Margin (%) | 12.49 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 16.58 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 77.56 | 339.9 |
| Expenses | N/A | N/A |
| PBT | 6.59 | 57.67 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 4.46 | 42.46 |
About Vasundhara Rasayans Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Rajesh Pokerna |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,77,311.70 | 1,989.35 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,13,878.74 | 8,056.65 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,94,094.11 | 5,130.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,28,759.16 | 8,960.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,991.58 | 1,473.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,12,368.81 | 1,126.50 | 835.50 - 835.50 |
| Lupin Ltd. | 1,10,374.22 | 2,418.30 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,06,918.95 | 1,098.55 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,02,005.88 | 2,469.90 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 98,126.10 | 1,816.25 | 810.05 - 810.05 |
No Records Found
Latest News
Divis Laboratories informs about outcome of board meeting
iStreet Network informs about disclosure
Pursuant to Regulation 30 of the SEBI (listing Obligation and Disclosure Requirement) Regulations, 2015, iStreet Network has informed that the company has received listing approval for 10,83,334 equity shares vide letter LOD/PREF/AP/FIP/591/2026-27 dated July 31, 2026 from BSE issued to non-promoter on preferential basis pursuant to conversion of warrants. The company has enclosed a copy of the Listing Approval of the BSE.
The above information is a part of company’s filings submitted to BSE.
RPG Life Sciences informs about superannuation of SMP
CORONA Remedies informs about newspaper advertisement
CORONA Remedies has informed the Board of Directors, at its meeting held on Friday, July 31, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the first quarter and three months ended on June 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com.
The above information is a part of company’s filings submitted to BSE.
Dr. Reddy’s Laboratories informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Vasundhara Rasayans Ltd. is ₹176.90 as of 2026-07-31.
The market capitalisation of Vasundhara Rasayans Ltd. is ₹56.22 as of 2026-07-31.
The 1-year return of Vasundhara Rasayans Ltd. is -26.10% as of 2026-07-31.
The P/E ratio of Vasundhara Rasayans Ltd. is 17.28 as of 2026-08-01.
The 52-week high and low of Vasundhara Rasayans Ltd. are ₹220.00 and ₹100.10, respectively, as of 2026-07-31.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
